[Quantification of JAK2V617F mutational burden in chronic myeloproliferative neoplasms]. [electronic resource]
- Medicina clinica Oct 2012
- 393-4 p. digital
Publication Type: Editorial; Comment
1578-8989
10.1016/j.medcli.2012.04.018 doi
Female Heterozygote Homozygote Humans Janus Kinase 2--genetics Male Myeloproliferative Disorders--genetics Phenotype Point Mutation